Response Assessment During MR-guided Radiation Therapy for Glioblastoma

RecruitingOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

September 1, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Glioblastoma Multiforme
Interventions
DEVICE

Low field (0.35 T) MR-images of the brain at a MRIdian® linac system

Low field (0.35 T) MR-images of the brain at a MRIdian® linac system using CE marked low-field MR coils as provided by the company will be taken for volunteers in phase I. In phase II and III, after therapy beginning those images will be taken once per week per subject using CE marked low-field MR coils as provided by the company. This is done over the entire course of radiotherapy, which takes between 3 and 6 weeks.

Trial Locations (1)

8091

RECRUITING

University Hospital Zurich, Zurich

All Listed Sponsors
lead

University of Zurich

OTHER